Immutep : Results of Annual General Meeting

ASX/Media Release

RESULTS OF ANNUAL GENERAL MEETING

SYDNEY, AUSTRALIA - 26 November 2021 - Immutep Limited(ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company") advises that the results of its Annual General Meeting (AGM) are set out in the attached document in accordance with section 251AA(2) of the Corporations Act 2001 (Cth) and Listing Rule 3.13.2.

Please be advised that all resolutions in the Company's 2021 Notice of Annual General Meeting were passed by the requisite majorities at today's AGM.

All resolutions were passed and decided by way of poll.

About Immutep

Immutep is a globally active biotechnology company that is a leader in the development of LAG-3 related immunotherapeutic products for the treatment of cancer and autoimmune disease. Immutep is dedicated to leveraging its technology and expertise to bring innovative treatment options to market for patients and to maximize value to shareholders. Immutep is listed on the Australian Securities Exchange (IMM), and on the NASDAQ (IMMP) in the United States.

Immutep's current lead product candidate is eftilagimod alpha ("efti" or "IMP321"), a soluble LAG-3 fusion protein (LAG-3Ig), which is a first-in-class antigen presenting cell (APC) activator being explored in cancer and infectious disease. Immutep is also developing an agonist of LAG-3 (IMP761) for autoimmune disease.

Additional LAG-3 products, including antibodies for immune response modulation, are being developed by Immutep's large pharmaceutical partners.

Further information can be found on the Company's website www.immutep.comor by contacting:

Australian Investors/Media:

Catherine Strong, Citadel-MAGNUS

[phone];[e-mail]

U.S. Media:

Tim McCarthy, LifeSci Advisors

+1 [phone];[e-mail]

This announcement was authorised for release by Deanne Miller, COO & Company Secretary of Immutep Limited.

Immutep Limited, Level 12, 95 Pitt Street, Sydney NSW 2000

ABN: 90 009 237 889

Immutep Limited

Annual General Meeting

Friday, 26 November 2021

Results of Meeting

The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2.

	Resolution details
	Resolution		Resolution
		Type
1.	Adoption of Remuneration		Ordinary
Report
2.	Re-election of Director - Dr		Ordinary
Russell Howard
3.	Ratification of previous Share		Ordinary
issue
4.	Approval of grant of
performance rights to Dr Russell		Ordinary
Howard
5.	Approval of the use of
performance rights and/or options		Ordinary
under the Company's Executive
Incentive Plan
6.	Approval of grant of
performance rights to Mr Marc		Ordinary
Voigt
7.	Approval of Amendment to		Special
Constitution
8.	Approval of Proportional		Special
Takeover Provisions

Instructions given to validly appointed proxies			Direct votes			Number of votes cast on the poll
	(as at proxy close)			(as at close of direct voting)			(where applicable)
For	Against	Proxy's	Abstain		For	Against	Abstain		For		Against		Abstain*
Discretion
274,582,622	1,160,762	1,803,064	843,134		9,845,075	127,337	30,024		286,579,383		1,290,099		873,158
									99.55%		0.45%
279,327,851	1,459,484	1,905,023	899,642		20,861,709	3,235	7,443		302,445,205		1,462,719		907,085
									99.52%		0.48%
218,401,812	2,041,473	1,659,093	57,037,067		20,373,847	310,667	187,873		240,785,374		2,352,140		57,224,940
									99.03%		0.97%
272,208,059	7,149,516	1,855,950	1,628,475		20,026,155	818,873	27,359		294,563,786		7,770,389		1,730,834
									97.43%		2.57%
273,775,534	7,596,947	1,865,950	353,569		9,545,972	582,987	2,989,664		285,461,078		8,181,934		3,418,233
									97.21%		2.79%
220,099,588	60,109,222	1,583,939	1,799,251		20,036,491	808,537	27,359		242,193,640		60,719,759		1,901,610
									79.95%		20.05%
273,727,014	7,591,483	1,521,081	752,422		20,459,980	333,623	78,784		296,058,697		7,925,106		831,206
									97.39%		2.61%
279,890,215	1,522,645	1,521,081	658,059		20,505,118	278,855	88,414		302,267,036		1,801,500		746,473
									99.41%		0.59%

Resolution		If s250U
Result		applies
Carried /
Not Carried
Carried		No

CarriedNA

CarriedNA

CarriedNA

CarriedNA

CarriedNA

CarriedNA

CarriedNA

* Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll.